Kerstin Hellwig

11.6k total citations · 1 hit paper
171 papers, 4.2k citations indexed

About

Kerstin Hellwig is a scholar working on Pathology and Forensic Medicine, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kerstin Hellwig has authored 171 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Pathology and Forensic Medicine, 75 papers in Immunology and 67 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kerstin Hellwig's work include Multiple Sclerosis Research Studies (98 papers), Reproductive System and Pregnancy (64 papers) and Pregnancy and Medication Impact (49 papers). Kerstin Hellwig is often cited by papers focused on Multiple Sclerosis Research Studies (98 papers), Reproductive System and Pregnancy (64 papers) and Pregnancy and Medication Impact (49 papers). Kerstin Hellwig collaborates with scholars based in Germany, United States and United Kingdom. Kerstin Hellwig's co-authors include Ralf Gold, Aiden Haghikia, Annette Langer‐Gould, Andrew Chan, Sandra Thiel, Ingo Kleiter, Sebastian Schimrigk, Carsten Lukas, Ilya Ayzenberg and Sandra Herbstritt and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kerstin Hellwig

154 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Smouldering multiple sclerosis: the ‘real MS’

2022 148 citations Kerstin Hellwig et al. Therapeutic Advances in Neurological Disorders profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kerstin Hellwig	2.9k	1.9k	1.2k	915	844	171	4.2k
Frances Lynn	3.6k 1.3×	1.1k 0.6×	431 0.4×	1.9k 2.0×	1.2k 1.4×	19	4.7k
J. Baskerville	3.3k 1.1×	398 0.2×	201 0.2×	596 0.7×	1.4k 1.6×	43	4.5k
Alexey Boyко	1.8k 0.6×	689 0.4×	107 0.1×	491 0.5×	670 0.8×	76	2.7k
A Wajgt	2.5k 0.9×	872 0.5×	306 0.3×	1.3k 1.4×	828 1.0×	37	3.3k
Jeffrey Cohen	2.4k 0.8×	701 0.4×	208 0.2×	776 0.8×	924 1.1×	52	3.0k
Emmanuelle Le Page	1.5k 0.5×	355 0.2×	162 0.1×	551 0.6×	633 0.8×	52	1.8k
Gavin Giovannoni	3.0k 1.0×	944 0.5×	276 0.2×	1.2k 1.3×	1.1k 1.3×	63	3.7k
Joachim Burman	1.6k 0.6×	686 0.4×	158 0.1×	814 0.9×	669 0.8×	111	2.8k
Joël Oger	1.4k 0.5×	339 0.2×	117 0.1×	443 0.5×	1.1k 1.3×	72	2.7k
Michael C. Frühwald	1.2k 0.4×	293 0.2×	527 0.4×	301 0.3×	588 0.7×	183	4.0k

Countries citing papers authored by Kerstin Hellwig

Since Specialization

Citations

This map shows the geographic impact of Kerstin Hellwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin Hellwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin Hellwig more than expected).

Fields of papers citing papers by Kerstin Hellwig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerstin Hellwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin Hellwig. The network helps show where Kerstin Hellwig may publish in the future.

Co-authorship network of co-authors of Kerstin Hellwig

This figure shows the co-authorship network connecting the top 25 collaborators of Kerstin Hellwig. A scholar is included among the top collaborators of Kerstin Hellwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerstin Hellwig. Kerstin Hellwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muller, D.R., Ruth Schneider, Sandra Thiel, et al.. (2025). Multiple Sclerosis Relapse Treatment During Pregnancy and Offspring Functional and Structural Neurodevelopment. Neurology. 105(9). e214217–e214217.

Thiel, Sandra, et al.. (2024). Schwangerschaft und Stillzeit bei Frauen mit Multipler Sklerose. Der Nervenarzt. 95(4). 329–334. 1 indexed citations

Otto, Ferdinand, et al.. (2024). Impact of Continuous Ofatumumab Exposure During Pregnancy in Multiple Sclerosis. Neurology Clinical Practice. 15(1). e200410–e200410.

Faissner, Simon, et al.. (2024). Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis. Therapeutic Advances in Neurological Disorders. 17. 4233510409–4233510409.

Merki‐Feld, Gabriele S., Riley Bove, Lisa B. Haddad, et al.. (2024). Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning. The European Journal of Contraception & Reproductive Health Care. 30(2). 59–73.

Dobson, Ruth, Sandra Vukusic, Riley Bove, et al.. (2024). 176. Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Approximately 4,000 Pregnancies To Date. Multiple Sclerosis and Related Disorders. 92. 106137–106137.

Hellwig, Kerstin, Celia Oreja‐Guevara, Ruth Dobson, et al.. (2024). 175. B-cell Levels in Infants of Lactating Women with Multiple Sclerosis Receiving Ocrelizumab: SOPRANINO Primary Results. Multiple Sclerosis and Related Disorders. 92. 106136–106136.

Huhn, Konstantin, et al.. (2023). Breastfeeding in Mothers with Multiple Sclerosis: The German Experience. Breastfeeding Medicine. 18(3). 241–245. 2 indexed citations

Thiel, Sandra, et al.. (2023). Ofatumumab in Breast Milk of Multiple Sclerosis Patients. Multiple Sclerosis and Related Disorders. 80. 105161–105161.

10.

Hellwig, Kerstin, et al.. (2023). Pregnancy outcomes in patients with MS following exposure to ofatumumab: Updated results (Novartis safety database). A66.3–A67.

11.

Krysko, Kristen M., Riley Bove, Ruth Dobson, Vilija Jokubaitis, & Kerstin Hellwig. (2021). Treatment of Women with Multiple Sclerosis Planning Pregnancy. Current Treatment Options in Neurology. 23(4). 11–11. 55 indexed citations

12.

Blaschke, Stefan, David Ellenberger, Peter Flachenecker, et al.. (2021). Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry. Multiple Sclerosis Journal. 28(6). 865–871. 9 indexed citations

13.

Richter, Daniel, Simon Faissner, Dirk Bartig, et al.. (2021). The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany. Therapeutic Advances in Neurological Disorders. 14. 4203311744–4203311744. 7 indexed citations

14.

Jokubaitis, Vilija, et al.. (2020). MS, pregnancy and COVID-19. Multiple Sclerosis Journal. 26(10). 1137–1146. 7 indexed citations

15.

Bove, Riley, Kelsey A. Rankin, Chao Zhao, et al.. (2019). Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis. Multiple Sclerosis Journal. 26(11). 1410–1419. 35 indexed citations

16.

Thiel, Sandra, et al.. (2018). Disease activity and disability after Natalizumab (NTZ) withdrawal due to planning a pregnancy in women with multiple sclerosis (P4.358). Neurology. 90(15_supplement). 1 indexed citations

17.

Thiel, Sandra, et al.. (2018). Low relapse risk under disease modifying treatment during ART in women with relapsing remitting multiple sclerosis (P4.356). Neurology. 90(15_supplement). 8 indexed citations

18.

Kümpfel, Tania, et al.. (2017). Long-term exposure to natalizumab during pregnancy - a prospective case series from the German Multiple Sclerosis and Pregnancy Registry. Multiple Sclerosis Journal. 4 indexed citations

19.

Hellwig, Kerstin, Sandra Herbstritt, & Ralf Gold. (2015). Glatiramer acetate and Pregnancy in women with Multiple Sclerosis - results from the German Multiple Sclerosis and Pregnancy Registry (P3.278). Neurology. 84(14_supplement). 1 indexed citations

20.

Haghikia, Aiden, Henriette Schneider, Tobias Tenenbaum, et al.. (2013). Natalizumb in Active MS during Pregnancy: Efficacy, Safety, and the Consequences for Foetal Haematopoiesis (P02.125). Neurology. 80(7_supplement). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact